Artiva Biotherapeutics
NK cell therapy for cancer patients. Learn more
Launch date
Employees
Market cap
$242m
Enterprise valuation
$211m (Public information from Sep 2024)
Share price
$11.73 ARTV
San Diego California (HQ)
Authorizing premium user...